Home > Research > Publications & Outputs > The use of tetrazolium assay in measuring the r...
View graph of relations

The use of tetrazolium assay in measuring the response of human tumour cells to ionising radiation.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The use of tetrazolium assay in measuring the response of human tumour cells to ionising radiation. / Price, Patricia; McMillan, Trevor J.
In: Cancer Research, Vol. 50, No. 5, 03.1990, p. 1392-1396.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Author

Price, Patricia ; McMillan, Trevor J. / The use of tetrazolium assay in measuring the response of human tumour cells to ionising radiation. In: Cancer Research. 1990 ; Vol. 50, No. 5. pp. 1392-1396.

Bibtex

@article{9d4e15137b9b4bd58cd9e0698933ac50,
title = "The use of tetrazolium assay in measuring the response of human tumour cells to ionising radiation.",
abstract = "Three human tumor cell lines of widely differing radiosensitivity were used to examine the characteristics of the 3-[4,5-dimethyl(thiazol-2-yl)-3,5-diphery]tetradium bromide (MTT) assay and to select suitable conditions for its use in assessing the response of cells to ionizing radiation. The optimal concentration of MTT and the time of incubation of the cells with MTT were individualized for each cell line. The relationship between absorbance and cell number was not linear over the wide range of cell numbers that were used. A calibration curve of absorbance against cell number for each cell line was therefore used. Using the assay to quantify metabolically viable cells, growth curves of irradiated and unirradiated cells were constructed on days 0–14 after irradiation. Accurate surviving fractions could be calculated only when cells were in exponential growth. Using this modification to its interpretation, the MTT assay was able to provide a reproducible measure of survival, which compared well with clonogenic cell survival measurements. However, the necessity to optimize conditions of the MTT assay for each cell line severely limits its usefulness in determining the radiosensitivity of cells in primary human tumor cultures.",
author = "Patricia Price and McMillan, {Trevor J.}",
year = "1990",
month = mar,
language = "English",
volume = "50",
pages = "1392--1396",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - The use of tetrazolium assay in measuring the response of human tumour cells to ionising radiation.

AU - Price, Patricia

AU - McMillan, Trevor J.

PY - 1990/3

Y1 - 1990/3

N2 - Three human tumor cell lines of widely differing radiosensitivity were used to examine the characteristics of the 3-[4,5-dimethyl(thiazol-2-yl)-3,5-diphery]tetradium bromide (MTT) assay and to select suitable conditions for its use in assessing the response of cells to ionizing radiation. The optimal concentration of MTT and the time of incubation of the cells with MTT were individualized for each cell line. The relationship between absorbance and cell number was not linear over the wide range of cell numbers that were used. A calibration curve of absorbance against cell number for each cell line was therefore used. Using the assay to quantify metabolically viable cells, growth curves of irradiated and unirradiated cells were constructed on days 0–14 after irradiation. Accurate surviving fractions could be calculated only when cells were in exponential growth. Using this modification to its interpretation, the MTT assay was able to provide a reproducible measure of survival, which compared well with clonogenic cell survival measurements. However, the necessity to optimize conditions of the MTT assay for each cell line severely limits its usefulness in determining the radiosensitivity of cells in primary human tumor cultures.

AB - Three human tumor cell lines of widely differing radiosensitivity were used to examine the characteristics of the 3-[4,5-dimethyl(thiazol-2-yl)-3,5-diphery]tetradium bromide (MTT) assay and to select suitable conditions for its use in assessing the response of cells to ionizing radiation. The optimal concentration of MTT and the time of incubation of the cells with MTT were individualized for each cell line. The relationship between absorbance and cell number was not linear over the wide range of cell numbers that were used. A calibration curve of absorbance against cell number for each cell line was therefore used. Using the assay to quantify metabolically viable cells, growth curves of irradiated and unirradiated cells were constructed on days 0–14 after irradiation. Accurate surviving fractions could be calculated only when cells were in exponential growth. Using this modification to its interpretation, the MTT assay was able to provide a reproducible measure of survival, which compared well with clonogenic cell survival measurements. However, the necessity to optimize conditions of the MTT assay for each cell line severely limits its usefulness in determining the radiosensitivity of cells in primary human tumor cultures.

M3 - Journal article

VL - 50

SP - 1392

EP - 1396

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 5

ER -